SUMMARY Lymphocytes from 39 patients with HBsAg positive chronic liver disease were incubated with their own hepatocytes to investigate mechanisms of lymphocyte-mediated liver damage. Cytotoxicity was significantly increased in 46% overall, and in 73% of those with chronic active hepatitis. Unlike HBsAg negative chronic active hepatitis where only non-T cells were cytotoxic, HBsAg positive patients had both cytotoxic T and non-T cells. A purified liver membrane complex (LSP) and aggregated IgG both blocked non-T cytotoxicity without affecting T cell cytotoxicity; this suggests that the former is probably an antibody-dependent cell-mediated reaction against normal membrane components. This was confirmed in preliminary studies which demonstrated that preincubation of hepatocytes with the F(ab)' fragment of an anti-human IgG reduced non-T lymphocyte cytotoxicity. T-cell cytotoxicity was restricted to HBeAg-positive 
In the investigation of immune reactions to liver cell membrane antigens, one approach is to incubate hepatocytes with peripheral blood lymphocytes from patients and to look for cytotoxic effects. [1] [2] [3] [4] Received for publication 1 March 1982 ensure histocompatibility between target and effector cells, which is probably required for optimum T cell cytotoxicity,7 we have incubated these hepatocytes with the patients' own lymphocytes. 8 We report here the results obtained with this autologous cytotoxicity assay in patients with a variety of liver diseases associated with chronic hepatitis B virus infection.
Methods PATI ENTS
Thirty-nine HBsAg positive patients were studied (34 men, mean age 32-9 years, range 17-69 years; five women, mean age 26.4 years, range 10-38 years). Of these, 27 (69%) had been found to be HBsAg positive on screening of high risk groups and had remained HBsAg positive for two to 72 months (median nine months). On review one year after the biopsy had been performed all patients had remained HBsAg positive. The other 12 had been persistently HBsAg positive after an acute hepatitis from seven to 228 months previously (median 26 months). All had persistently or intermittently abnormal liver function tests; a liver biopsy was performed for diagnostic purposes in all patients. None of the patients had received any immunosuppressive treatment before biopsy. Risk factors for acquiring the infection included male homosexuality (17 patients), drug addiction (three), tattoos (three), medical personnel (one), blood transfusion (one) ( Table 1) . Liver histology was assessed by a pathologist (BP) without prior knowledge of the biochemical or immunological findings, and the cytotoxicity values were calculated before the liver biopsy result was known. Each biopsy was scored for the following: mononuclear cell portal tract infiltrate, piecemeal necrosis, lobular infiltrate, lobular liver cell necrosis, liver cell hyperplasia, and fibrosis (absent=0, mild=1, moderate=2, severe=3). Patients were also allocated to one of four diagnostic categories: minor histological abnormalities, chronic persistent hepatitis, chronic active hepatitis, and chronic lobular hepatitis. Chronic persistent hepatitis and chronic active hepatitis were diagnosed according to internationally agreed criteria. Fifty millilitres of blood were taken at the time of biopsy and leucocyte rich plasma was obtained by sedimentation with 5 ml of 6% dextran containing 600 U of preservative-free heparin, and kept at room temperature. Twenty-four hours later, after dilution 1:1 with RPMI 1640 medium with glutamine (Flow Laboratories Ltd) the leucocyte-rich plasma was incubated in a cotton-wool column at 37°C for 15 minutes to remove macrophages.10 The leucocytes were then centrifuged over a FicollTriosil density gradient to remove the remaining neutrophils and red blood cells.1" After washing, the interface lymphocytes excluded trypan blue and contained less than 1% neutrophils and less than 5% macrophages. Subpopulations of lymphocytes were obtained by the method described previously.4 A T-cell enriched lymphocyte subpopulation was obtained by removing the cells bearing receptors for complement after rosetting with sheep red blood cells previously coated with the total immunoglobulin fraction of anti-sheep red blood cell serum and complement (EAC). The non-rosetted T cells were collected at the interface after centrifugation over a Ficoll-Triosil density gradient. In 23 experiments T cells were further purified: complementreceptor-bearing cells were first removed as described above but with IgM anti-sheep red blood cell antibody and complement, and then Fc-receptor bearing lymphocytes were removed by rosetting with sheep red blood cells coated with the total immunoglobulin fraction of anti-sheep red blood cell antiserum (EA). A non-T-cell enriched subpopulation was obtained by removing, on FicollTriosil, T lymphocytes after rosetting with sheep red blood cells. We have previously shown that T and non-T fractions prepared according to these techniques are contaminated with between 1 and 9% of non-T cells and between 1 and 25% of T cells respectively.8
The technique used for the microcytotoxicity assay was similar to that described previously.8 Two to three millimetres of human liver biopsy were used for the preparation of isolated hepatocytes. The liver was incubated at 37°C for four to five hours in RPMI-1640 containing 10% fetal calf serum, 001% collagenase, 1M Hepes 2*3%, penicillin 200 U/ml, streptomycin 100 gg/ml, and amphotericin B 2 ,g/ml, adjusted to a pH of 7.35 in an atmosphere of 95%02 and 5% CO2. was adjusted to produce a lymphocyte to hepatocyte ratio of 300:1. In 11 experiments a lower ratio (100:1) was also used when T cells were incubated with hepatocytes. Blocking experiments were performed in which 1 ,g of liver-specific lipoprotein was added to each test well. This was prepared as described previously12 except for the addition of a further purification step -namely, chromatography over Sepharose 2B, the material in the excluded volume being used in these blocking studies. Blocking experiments were also performed with 5
,ug of heat-aggregated IgG13 or 0.5 gg of purified HBsAg, prepared as described before.14 In some cases blocking studies were also performed preincubating the hepatocytes for two hours with 12 jig of an F(ab)' fragment of an antibody to human IgG, prepared according to Farr and Nakane.15
After incubation at 37°C for a further 48 hours, the plates were inverted for one hour and then gently washed with medium. The number of hepatocytes left in each well was counted at x60 magnification using a graticule eyepiece. The difference between the mean number of cells in control wells and that in test wells expressed as a fraction of the former gave the percentage cytotoxicity. In four cases T-cell cytotoxicity was also calculated after six hours' incubation and in 11 after 18 hours' incubation.
The normal range was determined with lymphocytes and hepatocytes from 11 HBsAg negative patients who were biopsied for diagnostic purposes, but showed no significant histological abnormalities (two patients with Gilbert's syndrome, two investigated for mild disturbances in liver function tests, three follow-up biopsies after acute hepatitis, one follow-up patient with granulomatous disease, one with diabetes, one with psoriasis. before starting treatment with methotrexate, one with portal vein thrombosis). The upper limit of normal in such a system calculated as 2 standard deviations above the mean was 32% for the undivided lymphocyte population, 32% for T cells, and 24% for non-T cells.
Results
Eight of the 11 patients (73%) with chronic active hepatitis had significantly increased lymphocyte cytotoxicity to autologous hepatocytes but this was uncommon in those with mild histological abnormalities (two of 12, 17%) (x2=7X34, p<0.001).
Patients with chronic persistent and chronic lobular hepatitis had intermediate values for frequency of cytotoxicity (Fig. 1) . Although only those patients with chronic active or chronic lobular hepatitis had cytotoxicity values greater than 50%, there was no significant correlation between diagnostic categories and the extent of the cytotoxicity in vitro (Fig. 1) . Subpopulations of the lymphocytes were prepared in all of the 39 cases. Of the 16 patients with increased cytotoxicity with the undivided lymphocyte population, seven had increased cytotoxicity values with both T and non-T cell subpopulations. Three patients had only T cell and six only non-T cell cytotoxicity. In seven of the remaining 23 patients who did not show increased cytotoxicity with the undivided lymphocyte fraction, cytotoxicity was significantly increased with one of the subpopulations: non-T cell in five cases and T cell in two. Changing the method of preparing T cells did not affect these findings. Thus T cell cytotoxicity was observed in seven of nine cases in which the T lymphocytes were prepared by removing cells forming EAC rosettes, and in seven of 10 cases in which the additional EA rosetting step was used.
No relation was found between the pattern of subpopulation cytotoxicity and histological categories ( Table 2 The effect of changing the ratio of T lymphocytes to hepatocytes was studied in 11 cases, four of whom showed positive cytotoxicity at the standard ratio of 300:1. All four were also cytotoxic at a lower ratio of 100:1. In four patients in whom significant T-cell cytotoxicity was present after the standard 48 hour culture (mean % cytotoxicity ± SD = 48±18) similar values were recorded after the shorter 18 hour culture (45±10). Attempts to examine T-cell cytotoxicity at six hours proved to be impossible because of poor attachment of hepatocytes in both control and test wells. TARGET 
ANTIGENS
The effect of adding liver specific lipoprotein to the microtest wells was examined in 11 cases with increased non-T cell cytotoxicity. In all 11, cytotoxicity values were substantially reduced and fell to within the normal range in nine cases. In contrast liver specific lipoprotein had little effect on T-cell cytotoxicity in eight cases tested (Fig. 2) . The addition of aggregated IgG gave similar results: non-T cytotoxicity was blocked in five of six cases tested, whereas T-cell cytotoxicity was not significantly affected (Fig. 3) . In three cases preincubation of the hepatocytes with the F(ab)' fragment of an antibody to human IgG blocked or reduced non-T cell cytotoxicity (Fig. 4) . When purified HBsAg was added to the culture wells, there was a variable decrease in T-cell cytotoxicity, with results in five cases falling within the normal range (Fig. 5) . Neither liver specific lipoprotein, aggregated IgG, nor HBsAg had a significant effect on autologous cytotoxicity in normal controls.
Discussion
These results show that about half of these patients with various types of chronic liver disease due to hepatitis B virus infection have increased lymphocyte cytotoxicity to their own hepatocytes. Although there was no absolute correlation with histological appearances, the frequency of cytotoxicity was significantly greater in those patients with the most severe and progressive form of liver damage -that is, chronic active hepatitis. In most patients with increased cytotoxicity this was mediated by cells in both the T and the non-T lymphocyte preparations.
Before assuming that both T and non-T effector cells are active in the assay, it is important to exclude the possibility that a non-specific effector cell, such as a natural killer cell which could have been present in both subpopulations, is responsible for the damaging effect. With respect to the non-T population, the blocking experiments show that effector cells here have Fc receptors and when cultured with aggregated IgG or the F(ab)' fragment of an anti-human IgG the cytotoxic effect is markedly reduced, suggesting that this is due to an antibody dependent cell-mediated reaction. Furthermore, non-T cell cytotoxicity is blocked by so. that the liver-damaging immune mechanisms in chronic active hepatitis associated with persistent viral infection may differ from those in the 'autoimmune' cases. Whereas a non-T, antibody dependent cell-mediated mechanism seems to play a role in both subgroups and is directed at normal membrane components, T cell killing also contributes to cell damage in those HBsAg-positive cases in which there is active virus replication.
It is difficult to be sure of the pathogenic significance of these findings. It is unlikely that the results obtained are a totally accurate reflection of the situation in vivo, as it seems inconceivable that such a high percentage of liver cells are continually being destroyed in these patients, many of whom are virtually asymptomatic. Other factors such as the physical separation of effector and target cells by endothelial cells lining the liver sinusoids are likely to interfere with the cytotoxic reaction in vivo. In addition, in patients with chronic hepatitis B infection membrane bound IgG is found on many virus infected hepatocytes20 and is associated with a reduced membrane expression of HBsAg. 21 Reduced viral expression on infected cells could impair immune clearance by T lymphocytes in vivo. When the hepatocytes are cultured in vitro in the absence of patient's serum it is possible that this modulatory effect of antibody may be rapidly overcome; viral antigens could then reappear on their surface rendering them susceptible to T-cell damage. Such a sequence of events has been shown clearly for measles-infected HeLa cells. 
